Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06521502
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-16
Brief Title:
The APS Phenotyping Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The ARDS Pneumonia and Sepsis APS Consortium A Prospective Observational Study to Evaluate Phenotypes
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of the observational APS phenotyping study is to better understand risk factors potential biomarkers length and severity of illness and recovery for adults with ARDS pneumonia and or sepsis This study will also generate a biobank of specimens collected from these patients that will be available to investigators for future studies of ARDS sepsis andor pneumonia
Detailed Description:
The APS phenotyping study will enroll hospitalized adult patients 18 years old who have or are at risk of developing ARDS sepsis or pneumonia Participation in this study will involve collection of clinical data completing questionnaires and collection of samples such as blood urine and stool Participants who are mechanically ventilated will also provide samples from their respiratory track Data and samples will be collected both during and after hospitalization Analyses to understand the mechanisms underlying ARDS pneumonia and sepsis will be conducted with goals including the classification of patients with ARDS pneumonia and sepsis into biologically based phenotype categories and identifying new targets for future therapeutic trials
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None